“…The maturation and insertion of [Fe–S] clusters into apo-target proteins require mitochondrial ISC assembly machinery that contains scaffold protein IscU, cysteine desulfurase (Nfs1), accessory protein Isd11, activator/iron donor Frataxin, and Ferredoxin (Agar et al, 2000; Colin et al, 2013; Cory et al, 2017; Johnson et al, 2005; Lill, 2009; Pandey et al, 2013; Raulfs, O’Carroll, Santos Dos, Unciuleac, & Dean, 2008; Schmucker et al, 2011; Tsai & Barondeau, 2010; Webert et al, 2014; Yoon & Cowan, 2003; Zheng, Cash, Flint, & Dean, 1998). [Fe–S] clusters are assembled in mitochondrial and cytosolic machineries (Braymer & Lill, 2017; Bridwell-Rabb, Fox, Tsai, Winn, & Barondeau, 2014; Lill et al, 2006), and clusters are transferred to apo-target proteins aided by chaperones HscA/HscB upon maturation (Bonomi, Iametti, Morleo, Ta, & Vickery, 2011; Chandramouli & Johnson, 2006; Fox, Chakrabarti, McCormick, Lindahl, & Barondeau, 2015; Fox, Das, Chakrabarti, Lindahl, & Barondeau, 2015; Uzarska, Dutkiewicz, Freibert, Lill, & Muhlenhoff, 2013; Vranish et al, 2015). Defects in Fe–S cluster assembly and maturation lead to multiple human diseases and protein dysfunctions (Rouault, 2015; Stehling, Wilbrecht, & Lill, 2014) that encompass many processes including metabolism, DNA maintenance, Fe–S cluster assembly machineries, respiratory chain metabolism, ribosome function, and tRNA modification (Andreini, Banci, & Rosato, 2016).…”